OMB.report

Federal forms, ICRs, and supporting documents

Information Collection Request

Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures

ICR 201302-0651-003 · OMB 0651-0024 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Form PTO/SB/93 Request for Transfer of a Computer Readable Form Under 37 CFR 1.821(e) Form Modified Repair queued
0651-0024-SupStmt-May2013-update.pdf Supporting Statement A Uploaded 2013-05-10 Available
0651-USPTO-InfoQuality-Guidelines-01_07_2013.pdf Supplementary Document Uploaded 2013-02-22 Available
r13ter.pdf Supplementary Document Uploaded 2009-12-02 Available
03-25-01.pdf Supplementary Document Uploaded 2006-09-13 Repair queued
IC Document Collections
IC IDCollectionTypeStatusForm
4695 Sequence Listing in Application (paper) Modified
45201 Electronic Sequence Listing in Application Modified
45200 Sequence Listing in Application (CD) Modified
190812 Request for Transfer of a Computer Readable Form Under 37 CFR 1.821(e) Form Modified
ICR Details
0651-0024 201302-0651-003
Historical Active 200909-0651-002
DOC/PTO
Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
Revision of a currently approved collection   No
Regular
Approved with change 05/14/2013
Retrieve Notice of Action (NOA) 02/25/2013
Supporting statement updated.
  Inventory as of this Action Requested Previously Approved
05/31/2016 36 Months From Approved 05/31/2013
25,250 0 19,750
138,225 0 103,750
2,546,400 0 920,959
Patent applications that contain nucleotide and/or amino acid sequence disclosures must include a copy of the sequence listing in accordance with the requirements in 37 CFR 1.821-1.825 and World Intellectual Property Organization (WIPO) Standard ST.25 (1998). Applicants may submit sequence listings for both U.S. and international patent applications. The sequence listings may be submitted on paper, compact disc, or electronically over the Internet. The USPTO uses the sequence listings to determine the patentability of the associated patent application and to support the publication of issued patents. Applicants use sequence data when preparing biotechnology patent applications and may also search sequence listings after publication.
US Code: 35 USC 22 Name of Law: null
  
None
Not associated with rulemaking
  77 FR 65537 10/29/2012
78 FR 12744 02/25/2013
No
  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 25,250 19,750 0 0 5,500 0
Annual Time Burden (Hours) 138,225 103,750 0 0 34,475 0
Annual Cost Burden (Dollars) 2,546,400 920,959 0 434,575 1,190,866 0
No
No
For this renewal, the USPTO estimates that the total annual responses and burden hours will increase from the currently approved burden for this collection due to administrative adjustments from updated annual response estimates. The estimated total annual (non-hour) cost burden will also increase due to both program changes and administrative adjustments. The program changes include an increase in fee amounts and the removal of capital start-up and recordkeeping costs from the requirements in this collection. The administrative adjustments include an increase in the estimated responses that may incur fees and increased costs due to increases in postage rates since the previous renewal.
$392,688
No
No
No
No
No
Uncollected
Raul Tamayo 5712727728 [email protected]
  No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/25/2013